Literature DB >> 24728424

Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value?

M Dalili1, K Vahidshahi, M Y Aarabi-Moghaddam, J Y Rao, P Brugada.   

Abstract

This study was conducted to evaluate the accuracy of exercise testing for predicting accessory pathway characteristics in children with Wolff-Parkinson-White (WPW) syndrome. The study enrolled 37 children with WPW syndrome and candidates for invasive electrophysiologic study (EPS). Exercise testing was performed for all the study participants before the invasive study. Data from the invasive EPS were compared with findings from the exercise testing. The sudden disappearance of the delta (Δ) wave was seen in 10 cases (27 %). No significant correlation was found between the Δ wave disappearance and the antegrade effective refractory period of the accessory pathway (AERP-AP) or the shortest pre-excited RR interval (SPERRI). The sensitivity, specificity, and positive and negative predictive values of Δ wave disappearance, based on AERP-AP as gold standard, were respectively 29.4, 80, 71.4, and 40 %. The corresponding values with SPERRI as the gold standard were respectively 23.8, 71.4, 71.4 and 23.8 %. Exercise testing has a medium to low rate of accuracy in detecting low-risk WPW syndrome patients in the pediatric age group.

Entities:  

Mesh:

Year:  2014        PMID: 24728424     DOI: 10.1007/s00246-014-0907-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  20 in total

1.  Radiofrequency ablation in children and adolescents: results in 154 consecutive patients.

Authors:  Jens Cosedis Nielsen; Hans Kottkamp; Christopher Piorkowski; Jin-Hong Gerds-Li; Hildegard Tanner; Gerhard Hindricks
Journal:  Europace       Date:  2006-05       Impact factor: 5.214

2.  PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS).

Authors:  Mitchell I Cohen; John K Triedman; Bryan C Cannon; Andrew M Davis; Fabrizio Drago; Jan Janousek; George J Klein; Ian H Law; Fred J Morady; Thomas Paul; James C Perry; Shubhayan Sanatani; Ronn E Tanel
Journal:  Heart Rhythm       Date:  2012-05-10       Impact factor: 6.343

3.  Noninvasive risk stratification techniques in pediatric patients with ventricular preexcitation.

Authors:  Richard J Czosek; Jeffrey B Anderson; Bradley S Marino; Katelyn Mellion; Timothy K Knilans
Journal:  Pacing Clin Electrophysiol       Date:  2011-05       Impact factor: 1.976

4.  Reproducibility of transesophageal pacing in patients with Wolff-Parkinson-White syndrome.

Authors:  R Fenici; M P Ruggieri; M di Lillo; P Fenici
Journal:  Pacing Clin Electrophysiol       Date:  1996-11       Impact factor: 1.976

5.  Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome.

Authors:  Robert M Campbell; Margaret J Strieper; Patricio A Frias; Kathryn K Collins; George F Van Hare; Anne M Dubin
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

6.  The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children.

Authors:  Vincenzo Santinelli; Andrea Radinovic; Francesco Manguso; Gabriele Vicedomini; Simone Gulletta; Gabriele Paglino; Patrizio Mazzone; Giuseppe Ciconte; Stefania Sacchi; Simone Sala; Carlo Pappone
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

7.  Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.

Authors:  A D Sharma; R Yee; G Guiraudon; G J Klein
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

8.  Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.

Authors:  F Gaita; C Giustetto; R Riccardi; L Mangiardi; A Brusca
Journal:  Am J Cardiol       Date:  1989-09-01       Impact factor: 2.778

9.  Use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome.

Authors:  Anne M Dubin; Kathryn K Collins; Nancy Chiesa; Debra Hanisch; George F Van Hare
Journal:  Cardiol Young       Date:  2002-05       Impact factor: 1.093

Review 10.  Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.

Authors:  Osmar Antonio Centurión; Akihiko Shimizu; Shojiro Isomoto; Atsushi Konoe
Journal:  Europace       Date:  2008-03       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.